Wt Brclys Usagg Ndur (AGND) 41.90 $AGND Rate Hikes Back

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 8:23 AM

Wt Brclys Usagg Ndur (AGND) 41.90 $AGND

Rate Hikes Back in Play: ETFs to Profit
Sweta Killa - Zacks Investment Research - Wed May 25, 9:05AM CDT
The interest rate hike surprisingly is back on the table for the summer months as per the April Fed minutes.
AMZN: 758.81 (+6.20), VCR: 127.87 (+0.14), STPP: 30.58 (-0.18), JPM: 63.97 (-0.13), REK: 16.31 (-0.18), WFC: 47.97 (-0.16), BRK.B: 144.27 (-0.15), XLF: 23.65 (-0.04), AGND: 41.90 (-0.20)

14 Hedged Bond ETFs to Diminish Rising Rate Risks
editor@etftrends.com (ETF Trends) - ETF Trends - Mon May 23, 4:07PM CDT
A rising interest rate environment will weigh on fixed-income portfolios. Bond traders do not need to sacrifice yield-generation to diminish rate risk. Instead, investors can look to rate-hedged or zero-duration bond exchange traded funds. A...
EMBH: 24.99 (+0.01), HYZD: 22.93 (+0.10), HYIH: 22.58 (unch), HYHG: 64.72 (+0.14), AGND: 41.90 (-0.20), HYGH: 85.77 (-0.26), HYND: 19.33 (+0.23), IGHG: 72.97 (-0.53), IGIH: 23.73 (-0.05), THHY: 22.50 (-0.17), LQDH: 92.59 (-0.08), CLYH: 24.26 (+0.10), AGZD: 47.69 (+0.01), EMIH: 24.39 (unch)

13 Secret Ways to Invest for the Fed Rate Hike
Tracey Ryniec - Zacks Investment Research - Tue Dec 15, 3:57PM CST
Eric Dutram and Tracey Ryniec discuss the hidden ways you can cash in on the Fed rate hike using ETFs.
HEDJ: 52.95 (+0.01), XRLV: 28.07 (-0.02), IAI: 39.20 (+0.01), IAT: 33.60 (-0.11), AGND: 41.90 (-0.20)

Zacks Investment Ideas feature highlights: CBOE Holdings, E-Trade Financial, WisdomTree Barclays U.S. Aggregate Bond Negative Duration Fund and Ex-Rate Sensitive Low Volatility Portfolio
Zacks Equity Research - Zacks Investment Research - Wed Dec 02, 8:30AM CST
Zacks Investment Ideas feature highlights: CBOE Holdings, E-Trade Financial, WisdomTree Barclays U.S. Aggregate Bond Negative Duration Fund and Ex-Rate Sensitive Low Volatility Portfolio
CBOE: 68.80 (+0.46), XRLV: 28.07 (-0.02), ETFC: 25.08 (-0.05), AGND: 41.90 (-0.20)

Before the Fed Rate Hike, Buy These Stocks and ETFs
Eric Dutram - ZACKS - Mon Nov 30, 11:00AM CST
If you believe that a Fed rate hike is coming soon, then you should definitely take a closer look at these stocks and ETFs.
CBOE: 68.80 (+0.46), XRLV: 28.07 (-0.02), ETFC: 25.08 (-0.05), AGND: 41.90 (-0.20)

How These 4 ETFs Will Benefit from a Rate Hike
Sweta Killa - Zacks Investment Research - Mon Nov 16, 9:20AM CST
Investor should focus on the areas/sectors that will benefit the most in the rising rate environment.
AMZN: 758.81 (+6.20), STPP: 30.58 (-0.18), VCR: 127.87 (+0.14), JPM: 63.97 (-0.13), WFC: 47.97 (-0.16), BRK.B: 144.27 (-0.15), XLF: 23.65 (-0.04), AGND: 41.90 (-0.20)

Guard Against Rising Rates with These ETFs
Zacks Equity Research - Zacks Investment Research - Fri Oct 30, 11:39AM CDT
Investors worried about an imminent lift-off and rising rates might consider these ETF investing ideas.
SNLN: 18.59 (unch), FLOT: 50.62 (unch), RE: 189.01 (-0.02), AGZD: 47.69 (+0.01), PFF: 40.27 (+0.10), BKLN: 23.20 (unch), SDP: 30.72 (-0.33), XLF: 23.65 (-0.04), RTH: 80.34 (+0.21), BIZD: 17.15 (+0.01), PNQI: 81.06 (-0.26), AGND: 41.90 (-0.20)

5 ETFs Strategies to Prepare for Higher Rates - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Wed Aug 05, 8:30AM CDT
Here are number of strategies that could prove extremely beneficial for ETF investors in the rising rate environment.
KRE: 40.10 (-0.18), STPP: 30.58 (-0.18), FLOT: 50.62 (unch), KBE: 31.83 (-0.12), REK: 16.31 (-0.18), XRLV: 28.07 (-0.02), AGZD: 47.69 (+0.01), SDP: 30.72 (-0.33), BKLN: 23.20 (unch), XLF: 23.65 (-0.04), AGND: 41.90 (-0.20)

5 ETFs Strategies to Prepare for Higher Rates
Sweta Killa - ZACKS - Wed Aug 05, 3:30AM CDT
Here are number of strategies that could prove extremely beneficial for ETF investors in the rising rate environment.
KRE: 40.10 (-0.18), STPP: 30.58 (-0.18), FLOT: 50.62 (unch), KBE: 31.83 (-0.12), REK: 16.31 (-0.18), XRLV: 28.07 (-0.02), AGZD: 47.69 (+0.01), SDP: 30.72 (-0.33), BKLN: 23.20 (unch), XLF: 23.65 (-0.04), AGND: 41.90 (-0.20)

Zacks Investment Ideas feature highlights: SPDR S&P Insurance ETF, S&P Regional Banking ETF, S&P 500 ex-Rate Sensitive Low Volatility Portfolio and WisdomTree Barclays U.S. Aggregate Bond Negative Duration Fund - Press Releases
Zacks Equity Research - Zacks Investment Research - Mon Jun 08, 8:30AM CDT
Zacks Investment Ideas feature highlights: SPDR S&P Insurance ETF, S&P Regional Banking ETF, S&P 500 ex-Rate Sensitive Low Volatility Portfolio and WisdomTree Barclays U.S. Aggregate Bond Negative Duration Fund
KBE: 31.83 (-0.12), XRLV: 28.07 (-0.02), KIE: 71.89 (-0.40), AGND: 41.90 (-0.20)

Worried About Higher Interest Rates? Buy These Four ETFs to Profit - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Fri Jun 05, 11:26AM CDT
Welcome higher interest rates with these exchange traded funds.
KBE: 31.83 (-0.12), XRLV: 28.07 (-0.02), KIE: 71.89 (-0.40), AGND: 41.90 (-0.20)

Negative Duration Bond ETFs: Right Time to Bet? - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue May 12, 8:00AM CDT
Negative duration bond ETFs could be a great way to tap the rising interest rate scenario.
HYND: 19.33 (+0.23), AGND: 41.90 (-0.20)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...